This country profile provides an overview of Niger’s progress in reaching those in need of mass NTD treatment based on 2017 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Download country profiles
Priorities for progress in Niger
- Niger is commended for the excellent progress made in 2017 in increasing coverage for LF, SCH and STH.
- As a priority, it is encouraged to work to systematically increase and maintain high annual coverage levels for all the four preventative chemotherapy NTDs that are endemic in Niger.
- Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.
Treatment coverage was not reported in 2016 and 72% in 2017.
Treatment coverage decreased from 52% in 2016 to 27% in 2017.
Treatment coverage was not reported in 2016 and 87% in 2017.
Treatment coverage was not reported in 2016 and 100% in 2017.
Niger does not require mass treatment for river blindness.